免疫检查点抑制剂相关的新发性低血清炎:使用FAERS的回顾性分析
Difei Lu1, Jun Yao1, Geheng Yuan1
1Department of Endocrinology, Peking University First Hospital, 100034, Beijing, P.R. China.
Endocrine
|July 4, 2024
概括
免疫检查点抑制剂相关的低血压炎 (ICI-hypophysitis) 在男性中更为常见,特别是那些接受组合治疗的人. 高龄和某些癌症表明结果不佳,而女性性别和抗CTLA-4单一治疗具有保护性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
背景情况:
- 免疫检查点抑制剂 (ICI) 可以引起与免疫相关的不良事件 (irAEs),包括缺血症.
- 了解ICI-hypophysitis的患病率和风险因素对于患者管理至关重要.
研究的目的:
- 调查ICI-hypophysitis的流行率和人口特征.
- 探索与ICI-hypophysitis预后相关的风险因素.
主要方法:
- 对于ICI-hypophysitis病例 (2007-2022) 的FAERS数据的回顾性分析.
- 对人口统计数据,同时发生的内分泌病变和临床结果的分析.
- 不同免疫治疗小组之间的比较.
主要成果:
- ICI-hypophysitis发生在1.46%的患者中.
- 组合疗法和抗CTLA-4药物增加了阴囊炎风险;男性报告风险更高.
- 高龄,肺癌和癌与严重的结局有关.
- 女性性别,抗CTLA-4单疗法和ICI相关糖尿病是保护因素.
结论:
- ICI-hypophysitis是一种男性占主导地位的irAE,通常与抗CTLA-4疗法有关.
- 临床意识对于患有诸如老年或特定癌症等风险因素的患者至关重要.
- 女性性别,抗CTLA-4单疗法和ICI相关糖尿病与更好的预后相关.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.